Cancer Risk in Hemodialysis Patients
Author Information
Author(s): Muacevic Alexander, Adler John R, Farah Amir, Tatakis Anna, Abboud Wisam, Saliba Hala, Armaly Zaher
Primary Institution: Nazareth Hospital Edinburgh Medical Missionary Society (EMMS)
Hypothesis
What are the incidence and characteristics of malignancies in patients undergoing hemodialysis?
Conclusion
The study highlights the incidence of malignancies among ESRD patients on hemodialysis, emphasizing the need for regular monitoring and early detection.
Supporting Evidence
- Out of 584 patients undergoing dialysis, 11 patients (2%) were diagnosed with cancer.
- The most common malignancies identified were colorectal carcinoma (28%) and lung carcinoma (27%).
- Hypertension was present in 82% and diabetes in 73% of cancer patients.
- 83% of cancers were diagnosed after the initiation of dialysis, with an average latency of 2.36 years.
Takeaway
Patients on dialysis can get cancer, and it's important to check for it regularly to catch it early.
Methodology
This retrospective descriptive study analyzed cancer incidence and characteristics in hemodialysis patients from 2012 to 2022.
Potential Biases
Potential for incomplete data due to the retrospective nature of the study.
Limitations
The study is limited by its small sample size and retrospective design, which may affect the generalizability of the findings.
Participant Demographics
The mean age of cancer patients was 76.5 years, with 73% male and 27% female.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website